STAR

Strides Pharma Science Share Price

₹1,497.80 -98.15 (-6.15%)

04 Dec, 2024 19:53

SIP TrendupStart SIP in STAR

Start SIP

Performance

  • Low
  • ₹1,469
  • High
  • ₹1,596
  • 52 Week Low
  • ₹482
  • 52 Week High
  • ₹1,675
  • Open Price₹1,585
  • Previous Close₹1,596
  • Volume1,001,077

Investment Returns

  • Over 1 Month -4.17%
  • Over 3 Month + 11.77%
  • Over 6 Month + 74.38%
  • Over 1 Year + 198.16%
SIP Lightning

Smart Investing Starts Here Start SIP with Strides Pharma Science for Steady Growth!

Invest Now

Strides Pharma Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 59.7
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 13,804
  • P/B Ratio
  • 6.7
  • Average True Range
  • 79.91
  • EPS
  • 22.36
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 7.71
  • RSI
  • 48.81
  • MFI
  • 39.79

Strides Pharma Science Financials

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹1,497.80
-98.15 (-6.15%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹1,518.13
  • 50 Day
  • ₹1,472.09
  • 100 Day
  • ₹1,354.28
  • 200 Day
  • ₹1,154.70

Resistance and Support

1520.82 Pivot Speed
  • R3 1,699.58
  • R2 1,647.67
  • R1 1,572.73
  • S1 1,445.88
  • S2 1,393.97
  • S3 1,319.03

What's your outlook on Strides Pharma Science?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic drugs. It focuses on niche therapeutic segments, including anti-retrovirals, oncology, and central nervous system, serving markets worldwide.

Strides Pharma Science has an operating revenue of Rs. 4,410.32 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 1% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 45% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 4% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 43 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Strides Pharma Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-24 Quarterly Results
2024-07-29 Quarterly Results
2024-05-22 Audited Results & Final Dividend
2024-01-30 Quarterly Results
2023-10-30 Quarterly Results
Date Purpose Remarks
2024-09-09 FINAL Rs.2.50 per share(25%)Final Dividend
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend

Strides Pharma Science F&O

Strides Pharma Science Shareholding Pattern

25.84%
10.8%
5.86%
30.08%
0.01%
18.57%
8.84%

About Strides Pharma Science

  • NSE Symbol
  • STAR
  • BSE Symbol
  • 532531
  • Managing Director & Group CEO
  • Mr. Badree Komandur
  • ISIN
  • INE939A01011

Similar Stocks to Strides Pharma Science

Strides Pharma Science FAQs

Strides Pharma Science share price is ₹1,497 As on 04 December, 2024 | 19:39

The Market Cap of Strides Pharma Science is ₹13804.1 Cr As on 04 December, 2024 | 19:39

The P/E ratio of Strides Pharma Science is 59.7 As on 04 December, 2024 | 19:39

The PB ratio of Strides Pharma Science is 6.7 As on 04 December, 2024 | 19:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23